Literature DB >> 9705270

Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA polymerase IIo complexes.

R C Pillutla1, Z Yue, E Maldonado, A J Shatkin.   

Abstract

Guanine N-7 methylation is an essential step in the formation of the m7GpppN cap structure that is characteristic of eukaryotic mRNA 5' ends. The terminal 7-methylguanosine is recognized by cap-binding proteins that facilitate key events in gene expression including mRNA processing, transport, and translation. Here we describe the cloning, primary structure, and properties of human RNA (guanine-7-)methyltransferase. Sequence alignment of the 476-amino acid human protein with the corresponding yeast ABD1 enzyme demonstrated the presence of several conserved motifs known to be required for methyltransferase activity. We also identified a Drosophila open reading frame that encodes a putative RNA (guanine-7-)methyltransferase and contains these motifs. Recombinant human methyltransferase transferred a methyl group from S-adenosylmethionine to GpppG 5'ends, which are formed on RNA polymerase II transcripts by the sequential action of RNA 5'-triphosphatase and guanylyltransferase activities in the bifunctional mammalian capping enzyme. Binding studies demonstrated that the human cap methyltransferase associated with recombinant capping enzyme. Consistent with selective capping of RNA polymerase II transcripts, methyltransferase also formed ternary complexes with capping enzyme and the elongating form of RNA polymerase II.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705270     DOI: 10.1074/jbc.273.34.21443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Requirements of the RNA polymerase II C-terminal domain for reconstituting pre-mRNA 3' cleavage.

Authors:  Kevin Ryan; Kanneganti G K Murthy; Syuzo Kaneko; James L Manley
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.

Authors:  P Komarnitsky; E J Cho; S Buratowski
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 3.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

4.  Characterization of a Trypanosoma brucei RNA cap (guanine N-7) methyltransferase.

Authors:  Megan P Hall; C Kiong Ho
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

Review 5.  Chemical Modifications in the Life of an mRNA Transcript.

Authors:  Sigrid Nachtergaele; Chuan He
Journal:  Annu Rev Genet       Date:  2018-09-19       Impact factor: 16.830

6.  Yeast and Human RNA polymerase II elongation complexes: evidence for functional differences and postinitiation recruitment of factors.

Authors:  Timothy S Pardee; Mohamed A Ghazy; Alfred S Ponticelli
Journal:  Eukaryot Cell       Date:  2003-04

7.  Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.

Authors:  Michel Liuzzi; Stephen W Mason; Mireille Cartier; Carol Lawetz; Robert S McCollum; Nathalie Dansereau; Gordon Bolger; Nicole Lapeyre; Yvon Gaudette; Lisette Lagacé; Marie-Josée Massariol; Florence Dô; Paul Whitehead; Lyne Lamarre; Erika Scouten; Josée Bordeleau; Serge Landry; Jean Rancourt; Gulrez Fazal; Bruno Simoneau
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 8.  Regulation of mRNA cap methylation.

Authors:  Victoria H Cowling
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

9.  Poly(A) signal-dependent degradation of unprocessed nascent transcripts accompanies poly(A) signal-dependent transcriptional pausing in vitro.

Authors:  Amir Kazerouninia; Benson Ngo; Harold G Martinson
Journal:  RNA       Date:  2009-11-19       Impact factor: 4.942

10.  Mammalian capping enzyme binds RNA and uses protein tyrosine phosphatase mechanism.

Authors:  Y Wen; Z Yue; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.